Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“The first federally supported trials are expected to study ibogaine in adults with opioid use disorder (OUD) and adults with post‑traumatic stress disorder (PTSD).”
UnverifiableConfidence: LOW

Reasoning

The claim states that the first federally supported trials will study ibogaine for OUD and PTSD, but without any provided sources, there is no way to verify this information.

On confidence: No evidence was supplied to confirm or refute the claim.

Evidence

No retrievable evidence was found; the verdict rests on the reporting itself and is marked accordingly.

Limitations

The assessment is limited by the absence of any supporting documents or references.

Last verified:
Oct 6, 2026, 4:16 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information

Federal Register · Drug Administration, Human Services Department, Food, Health